CONDITION

Hyphaema

Hyphaema describes blood present in the anterior chamber — the fluid-filled space at the front of the eye, between the cornea and the iris. When blood accumulates there, it may appear as a reddish layer at the bottom of the eye, a diffuse cloudiness, or complete obscuring of normal eye structures. The amount can vary from a faint tinge to a chamber filled entirely with blood. Owners often notice this when the eye appears visibly red inside (distinct from surface redness), when the normally clear front of the eye looks clouded or discoloured, or when the pupil is difficult to see. It can develop suddenly or over hours, and may occur in one eye or both. The blood itself comes from vessels within the eye, though the reason those vessels have bled varies widely — from trauma to inflammation to changes in pressure or clotting. This page explores the patterns that tend to accompany hyphaema, the mechanisms that can lead to bleeding inside the eye, the ways it is investigated, and the approaches used to manage it.

Why this matters now

Hyphaema can occur at any age, though the underlying causes often differ by life stage. Young animals may develop it following trauma or as part of inherited bleeding disorders, while middle-aged and older pets more commonly show hyphaema linked to high blood pressure, clotting abnormalities, or growths within the eye. Certain breeds carry higher risk for conditions that predispose to intraocular bleeding, including those prone to hypertension or inherited eye disease. The trigger may be as immediate as blunt force or as gradual as a slowly rising pressure inside the eye.

The blood may appear suddenly, sometimes within minutes of an injury, or accumulate over hours if the bleeding is slower. In some animals the hyphaema remains stable, a static layer that gradually clears as the blood is reabsorbed. In others it worsens, with fresh bleeding adding to what is already present, or complications such as clot formation or pressure changes developing over days. The course depends heavily on the underlying cause and whether that cause remains active or resolves.

Signals & patterns

Early signals

Red or pink tinge inside the eye

The owner may notice a subtle pink or red colour visible through the normally clear front part of the eye, often pooling at the bottom if the pet holds its head upright. This can look different from surface redness of the white of the eye.

Cloudiness where the eye was clear

The anterior chamber may lose its transparency, appearing hazy or murky rather than glassy. This can make it harder to see the iris detail or pupil edge clearly.

Squinting or holding the eye partly closed

Blood in the anterior chamber often causes discomfort, and many animals respond by narrowing the eyelids on the affected side. The squint may be constant or intermittent.

Visible layering of red fluid

If enough blood has collected, it may settle as a distinct horizontal layer at the bottom of the chamber, creating a clear boundary between red and clear zones when the animal is upright.

Later signals

Complete reddening of the chamber

In more advanced cases, blood may fill the entire space, obscuring the iris and pupil completely. The front of the eye appears uniformly dark red or brown.

Change in eye pressure or size

Persistent or recurrent bleeding can alter the drainage of fluid from the eye, sometimes causing the eye to feel firmer or appear slightly larger. This may develop over days.

Darkening or discolouration of blood

Blood that has been present for some time often shifts from bright red to darker brown or rust tones as it breaks down. This colour change reflects the ageing of red cells within the chamber.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with observation of the eye itself — the amount and distribution of blood, whether one or both eyes are affected, and any changes in the appearance of surrounding structures. History often provides clues: recent trauma, onset speed, other signs noticed at home. From there, the focus shifts to identifying the source of bleeding, which may involve examining the eye's internal structures, measuring pressure, and exploring systemic factors that can compromise vessels or clotting.

Ophthalmic examination

Purpose: Direct visualisation of the anterior chamber, pupil response, and surrounding tissues helps assess the volume of blood, detect clots or fibrin, and identify signs of trauma, inflammation, or structural abnormalities within the eye. Examination may include slit-lamp biomicroscopy to view fine detail or tonometry to measure intraocular pressure.
Considerations: Dense hyphaema can obscure structures behind it, limiting what can be seen. Sedation or anaesthesia may be needed if the animal is painful or anxious, and pressure measurement must be gentle to avoid worsening any existing injury.

Blood pressure measurement

Purpose: Systemic hypertension can damage delicate intraocular vessels, and measuring blood pressure helps determine whether elevated readings may be contributing to or sustaining the bleeding.
Considerations: Stress during handling can transiently raise readings, so multiple measurements or home monitoring may be needed for accuracy. Normal pressure does not rule out a hypertensive episode that has since resolved.

Haematology and coagulation profile

Purpose: Blood tests can reveal low platelet counts, clotting factor deficiencies, or anaemia that might explain why bleeding has occurred or why it persists. Tests may include platelet numbers, clotting times, and sometimes specific assays for inherited bleeding disorders.
Considerations: Normal results do not exclude a localised eye problem unrelated to systemic clotting. Some clotting disorders are intermittent or mild enough that screening tests may not detect them outside an active bleeding episode.

Ocular ultrasonography

Purpose: Ultrasound allows visualisation of structures behind the blood — the lens, vitreous, retina, and posterior chamber — when direct viewing is blocked. It can identify retinal detachment, masses, or signs of trauma that are otherwise hidden.
Considerations: Image quality depends on operator skill and the degree of intraocular haemorrhage. It provides anatomical information but cannot always distinguish between inflammation, tumour, and other soft-tissue changes without further context.

Biochemistry and urinalysis

Purpose: Kidney and liver function tests, along with urine protein measurement, help identify systemic diseases such as chronic kidney disease or liver dysfunction that may underlie hypertension or clotting abnormalities.
Considerations: Abnormalities may indicate contributing factors rather than direct causes of hyphaema. Results are most useful when interpreted alongside other findings, as isolated changes can reflect unrelated conditions.

Options & trade-offs

Management is typically tailored to the underlying cause, the severity of bleeding, and the presence of complications such as raised pressure or ongoing inflammation. Many cases involve a combination of approaches — some addressing the eye directly, others targeting systemic factors. What proves workable varies with the individual animal's temperament, the owner's capacity for intensive treatment at home, and how the eye responds in the days following diagnosis.

Topical anti-inflammatory therapy

Steroid or non-steroidal anti-inflammatory drops or ointments are often applied to the eye to reduce inflammation, stabilise the blood-aqueous barrier, and limit further leakage from vessels. Frequency of application varies, sometimes requiring dosing several times daily. The aim is to create conditions that favour reabsorption of blood and discourage fresh bleeding.

Trade-offs: Topical steroids can raise intraocular pressure in some individuals, and their use may be limited if infection is suspected or if corneal ulceration is present. Administration can be challenging in animals that resist handling, and improvement may take days to become apparent.

Intraocular pressure management

If pressure inside the eye rises — whether from clot obstructing drainage or inflammation disrupting fluid balance — medications to lower pressure may be used. These can include topical beta-blockers, carbonic anhydrase inhibitors, or prostaglandin analogues, each working through different mechanisms to reduce aqueous production or enhance outflow.

Trade-offs: Some pressure-lowering drugs can cause local irritation or systemic side effects, and not all animals tolerate every class. Monitoring pressure over time is often needed to adjust therapy, which requires repeat visits or home tonometry if available.

Systemic blood pressure control

When hypertension is identified as a contributor, oral medications to lower systemic pressure may be introduced. Commonly used drugs include amlodipine or other calcium-channel blockers, adjusted over weeks to achieve stable control. Lowering pressure can reduce strain on intraocular vessels and decrease the likelihood of recurrent bleeding.

Trade-offs: Blood pressure control is a long-term commitment, often lifelong, and requires periodic monitoring to ensure targets are met without causing hypotension. Response varies, and some animals need dose adjustments or additional drugs. The hyphaema may persist even after pressure is normalised if other factors are also at play.

Rest and activity modification

Limiting vigorous activity, play, and head shaking can reduce the mechanical forces that might dislodge clots or provoke fresh bleeding. This often means quiet time indoors, short lead walks, and avoidance of rough interaction with other animals. The aim is to provide a stable environment while the eye heals.

Trade-offs: Restricting activity can be difficult in young or energetic animals, and compliance depends on household routine and the animal's temperament. Even with careful management, some bleeding may recur if the underlying cause remains active.

Treatment of underlying systemic disease

If investigation reveals a clotting disorder, infection, or neoplastic process, management of that condition becomes part of the overall approach. This might involve immunosuppressive drugs, antimicrobials, chemotherapy, or other therapies specific to the diagnosis. The eye is then monitored as the systemic treatment takes effect.

Trade-offs: Systemic therapies can carry their own side effects and costs, and response may be gradual or incomplete. The hyphaema may improve, stabilise, or persist depending on how well the underlying disease is controlled. In some cases, the eye problem is one manifestation of a broader illness that requires ongoing care.

Common misconceptions

Misconception:

"Hyphaema will clear on its own without any intervention, much like a bruise on the skin."

Reality:

While the blood in the anterior chamber can be reabsorbed over time, the process is not always benign. Complications such as clot formation, pressure changes, or recurrent bleeding can develop, and the underlying cause often requires attention to prevent worsening or recurrence. The eye's environment is more sensitive to disruption than subcutaneous tissue, and what appears static may be at risk of deterioration.

Misconception:

"If the animal is not squinting or pawing at the eye, the hyphaema is not causing discomfort."

Reality:

Pain in the eye can be subtle, and some animals show little outward sign even when intraocular pressure is elevated or inflammation is present. Behaviour such as reduced activity, reluctance to be touched near the head, or changes in appetite can reflect ocular discomfort. The absence of obvious distress does not mean the eye is unaffected.

Misconception:

"Once the blood has cleared, the eye has fully recovered."

Reality:

Resolution of visible blood does not always indicate that the underlying problem has resolved. Structural damage, persistent inflammation, or the disease that caused the bleeding may remain. Some animals develop complications such as glaucoma, lens luxation, or retinal detachment weeks or months later, even after the chamber appears clear. Ongoing monitoring is often part of the picture.

Hyphaema often sits at the intersection of ocular and systemic health, and understanding its context can involve exploring related patterns — how blood pressure affects the eye, what clotting disorders look like across the body, or how inflammation in one structure can spread to others. The broader themes within immune and inflammatory health may offer useful background, and questions about monitoring, recurrence risk, or long-term changes in vision can shape conversations as the picture becomes clearer. What you observe at home, and how the eye responds over days, adds detail that informs the next steps.

Last reviewed: 1 July 2026 · Dr Alastair Greenway MRCVS